A new cancer detection test to analyze volatile organic compounds through urine analysis, was granted the Breakthrough Device Designation status by the U.S. FDA. The system, which is built on gas ...

Under the new spending bill, the nation’s largest abortion provider would have to stop offering abortion in some states or ...

A woman living with early-onset Alzheimer's disease says more needs to be done for people in her situation. Nicola Wallis, 62 ...

Exclusive: Artificial intelligence is being used for the first time in IVF treatment in Australia, making it quicker and less ...

SAN ANTONIO, June 26, 2025--bioAffinity scientists present breakthrough research on using siRNAs to knock down two receptors ...

Charles Coristine thrived in pressure-packed environments when Morgan Stanley (NYSE: MS) hired him as a trader in the early 1990s. Twenty years later, he was suffering from severe burnout. He tried ...

Treatment options for progressive MS are more limited, however, and Sanofi is hoping that tolebrutinib can become the first medicine to target so-called 'smouldering' neuroinflammation.

PerkinElmer's latest LC-MS advancements aim to streamline sample preparation, enhancing performance and reliability for ...

From June 24 to 26, the World Economic Forum 2025 Annual Meeting of the New Champions (the 16th Summer Davos Forum) was held ...

Denali Therapeutics remains an intriguing clinical-stage biotech focused on neurodegenerative and lysosomal storage diseases.

For the past six years, it has ranked among the world’s top 20 medical schools. Read more at straitstimes.com. Read more at ...